Enter to open, tab to navigate, enter to select
Antitrust risk-shifting provisions in Medira Inc./Medical Action Industries Inc. purchase agreement
| March 12, 2014 • Antitrust Risk-shifting • $75.17 million (subject to purchase price adjustment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.